CSIR Licenses Private Path Lab for Genetic Tests

by Colleen Fleiss on  March 11, 2018 at 1:01 AM Genetics & Stem Cells News
RSS Email Print This Page Comment bookmark
Font : A-A+

The Council of Scientific and Industrial Research (CSIR) authorized a private lab for 27 genetic tests, revealed sources. These tests are expected to be launched over the period of one year.
CSIR Licenses Private Path Lab for Genetic Tests
CSIR Licenses Private Path Lab for Genetic Tests

"Genetic diseases, though are individually rare, cumulatively affect a large number of individuals -- an estimated 70 million Indians.

Show Full Article


"It is anticipated that the wide network of Dr Lal PathLabs would enable easy access to the genetic tests to large number of patients across the country and potentially enable wide utility of genetic tests by clinicians," said a statement from the CSIR.

According to the CSIR, mostly an appropriate diagnosis is not arrived at due to lack of general awareness on genetic diseases, lack of access and high cost of appropriate genetic diagnostic services.

"It is estimated that an average patient with rare disease has to go through multiple healthcare visits and diagnostic tests and takes approximately seven years to arrive at a precise diagnosis," the CSIR said.

Genomics, however, look at the individual case and figures out a personalise case for better treatment.

It added that so far through the CSIR-IGIB's previous efforts, over 14,000 genetic tests have been carried out, benefiting over 4,000 needy patients from across the country through a clinical network encompassing over 25 major medical centres spanning the length and breadth of the country.

"CSIR has a major focus on R&D pertaining to Affordable Health Care. The tests developed and licensed to Dr Lal PathLabs would provide a much needed support system to the doctors in diagnosing the identified genetic disorders," said Dr Girish Sahni, Director General, CSIR.

Source: IANS

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive